Novocure Ltd
NASDAQ:NVCR
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
11.83
33.41
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Novocure Ltd
Wall Street
Price Targets
NVCR Price Targets Summary
Novocure Ltd
According to Wall Street analysts, the average 1-year price target for
NVCR
is 35.7 USD
with a low forecast of 29.29 USD and a high forecast of 44.1 USD.
NVCR Last Price Targets
Novocure Ltd
The latest public price target was made on Oct 16, 2024 by
Emily Bodnar
from
H.C. Wainwright
,
who expects
NVCR
stock to
drop by 3%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
|
Emily Bodnar
H.C. Wainwright
|
30
USD
Downside 3% |
2 months ago
Oct 16, 2024
|
H.C. Wainwright Upgrades NovoCure Ltd. (NVCR) to Buy
StreetInsider
|
|
Emily Bodnar
H.C. Wainwright
|
24
USD
Downside 23% |
4 months ago
Jul 26, 2024
|
NovoCure Ltd. (NVCR) PT Raised to $24 at H.C. Wainwright
StreetInsider
|
|
Emily Bodnar
H.C. Wainwright
|
22
USD
Downside 29% |
7 months ago
May 3, 2024
|
NovoCure Ltd. (NVCR) PT Lowered to $22 at H.C. Wainwright
StreetInsider
|
Vijay Kumar
Evercore ISI
|
14.5
USD
Downside 53% |
7 months ago
May 2, 2024
|
NovoCure Ltd. (NVCR) PT Lowered to $14.50 at Evercore ISI
StreetInsider
|
Jason Bednar
Piper Sandler
|
28
USD
Downside 10% |
8 months ago
Apr 10, 2024
|
NovoCure Ltd. (NVCR) PT Raised to $28 at Piper Sandler
StreetInsider
|
Larry Biegelsen
Wells Fargo
|
42
USD
Upside 36% |
8 months ago
Apr 3, 2024
|
NovoCure Ltd. (NVCR) PT Lowered to $42 at Wells Fargo
StreetInsider
|
|
Unknown Analyst
H.C. Wainwright
|
24
USD
Downside 23% |
8 months ago
Mar 27, 2024
|
NovoCure Ltd. (NVCR) PT Raised to $24 at H.C. Wainwright following positive METIS data
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is NVCR's stock price target?
Price Target
35.7
USD
According to Wall Street analysts, the average 1-year price target for
NVCR
is 35.7 USD
with a low forecast of 29.29 USD and a high forecast of 44.1 USD.
What is Novocure Ltd's Revenue forecast?
Projected CAGR
14%
For the last 8 years the
compound annual growth rate for
Novocure Ltd's revenue is
41%.
The projected
CAGR
for the next 4 years is
14%.
You don't have any saved screeners yet
